Adicet Bio

1. Prula-cel RA Ph1 interim2H 2026Prula-cel RA Ph1 interim, 2H 2026, material
2. Prula-cel / pivotal program start2H 2026Prula-cel / pivotal program start, 2H 2026, notable
3. in vivo CAR-T platform readout2H 2026in vivo CAR-T platform readout, 2H 2026, notable
4. ADI-212 trial start4Q 2026ADI-212 trial start, 4Q 2026, routine
5. Prula-cel interim1H 2027Prula-cel interim, 1H 2027, material
6. Systemic sclerosis (SSc) program readout1H 2027Systemic sclerosis (SSc) program readout, 1H 2027, notable
7. In vivo CAR-T pipeline corporate2H 2027In vivo CAR-T pipeline corporate, 2H 2027, routine
8. in vivo candidate corporate update2H 2027in vivo candidate corporate update, 2H 2027, routine

Bar width shows how precise the guidance is — a pin is a stated date, a wide band a six-month window. Deeper blue means more of the thesis rides on the event; it is not a view on the stock.